RxDoctor Payments Data

Mary Naguit, MD

Family Medicine · Canonsburg, PANPI 1801024955

Payments from drug & device makers

$20,963in general payments, 2019–2025

Across 1,244 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novo Nordisk$2K
  • Pfizer$1K
  • GSK$1K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • plus $10K from 54 others

What the payments were for

  • Speaking & faculty fees$160%
  • Food & beverage$20,919100%
  • Education$280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)208$3,742
Novo Nordisk115$1,767
Pfizer96$1,440
GSK82$1,359
Lilly USA, LLC90$1,341
Amgen74$1,279
AstraZeneca48$1,187
Johnson & Johnson50$849
Boehringer Ingelheim48$675
Abbott36$601
Otsuka America Pharmaceutical, Inc.29$595
E.r. Squibb & Sons, L.L.C.30$486
Sanofi-aventis U.S. LLC40$464
Bayer23$366
Teva Pharmaceuticals USA, Inc.20$330
Takeda Pharmaceuticals U.S.A., Inc.23$326
Lundbeck LLC19$319
Novartis18$292
Sunovion Pharmaceuticals Inc.24$276
Phathom Pharmaceuticals, Inc.10$256
Ardelyx, Inc.10$211
Amarin Pharma, Inc.11$208
Collegium Pharmaceutical, Inc.12$202
Exact Sciences9$175
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$175
Biohaven Pharmaceuticals, Inc.11$168
Daiichi Sankyo Inc.7$161
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$123
Shield Therapeutics Inc4$122
Dexcom, Inc.7$122
Biohaven Pharmaceutical Holding Company Ltd.7$111
Kowa Pharmaceuticals America, Inc.7$105
Almatica Pharma LLC5$103
Merck7$96
Scilex Pharmaceuticals Inc.2$86
Pulmonx Corporation2$80
Astellas Pharma US Inc4$77
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$62
Avanir Pharmaceuticals, Inc.4$58
Xeris Pharmaceuticals, Inc.3$57
Endo Pharmaceuticals Inc.3$53
Esperion Therapeutics, Inc.3$46
Vivus LLC3$46
Eisai Inc.2$44
Upsher-smith Laboratories LLC1$29
Tonix Medicines, Inc.1$29
Vertical Pharmaceuticals, LLC2$25
Corium, LLC2$23
Alkermes, Inc.1$20
Verona Pharma, Inc.1$19
Idorsia Pharmaceuticals US Inc1$19
UCB, Inc.1$17
Acorda Therapeutics, Inc1$16
Aimmune Therapeutics, Inc.1$16
Heartflow, Inc.1$16
Organon1$16
Currax Pharmaceuticals LLC1$14
Ironwood Pharmaceuticals, Inc1$14
Biodelivery Sciences International, Inc.1$13
Medtronic1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,963 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$61,583
Medicare patients
121
Services billed
826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban198$127,174
OzempicSemaglutide102$105,699
Enbrel SureclickEtanercept11$77,039
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$52,722
XareltoRivaroxaban46$45,038
LinzessLinaclotide46$39,873
JardianceEmpagliflozin39$39,154
MounjaroTirzepatide28$28,947
FarxigaDapagliflozin Propanediol17$17,097
TrulicityDulaglutide12$13,873
Repatha SureclickEvolocumab23$12,655
RybelsusSemaglutide12$11,037
EntrestoSacubitril/Valsartan13$9,789
Repatha SyringeEvolocumab22$7,276
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$7,112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$1,440$131,462217 claims
Novo NordiskOzempic, Rybelsus$1,767$116,736114 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,359$59,41574 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat$675$52,84062 claims
Johnson & JohnsonXarelto$849$45,03846 claims
AbbVieLinzess, Synthroid$3,742$43,729132 claims
Lilly USA, LLCMounjaro, Trulicity$1,341$42,82040 claims
AstraZenecaFarxiga, Nexium$1,187$20,12529 claims
NovartisEntresto$292$9,78913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Canonsburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →